Clinical Trials List
2016-04-01 - 2020-11-30
Phase III
Terminated3
ICD-10M06.9
Rheumatoid arthritis, unspecified
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 黃建中 風濕免疫科
- Po-Hao Huang 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- KO-JEN LI 風濕免疫科
- CHENG-HAN WU 風濕免疫科
- CHIEH-YU SHEN 風濕免疫科
- PING-NING HSU 風濕免疫科
- 郭佑民 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- 童建學 Division of Rheumatology
- 許寶寶 Division of Rheumatology
- 黃光永 Division of Rheumatology
- CHENG-HAN WU Division of Rheumatology
- 呂明錡 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
975 participants
